JP2014532718A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532718A5
JP2014532718A5 JP2014540118A JP2014540118A JP2014532718A5 JP 2014532718 A5 JP2014532718 A5 JP 2014532718A5 JP 2014540118 A JP2014540118 A JP 2014540118A JP 2014540118 A JP2014540118 A JP 2014540118A JP 2014532718 A5 JP2014532718 A5 JP 2014532718A5
Authority
JP
Japan
Prior art keywords
polypeptide
conductivity
elution buffer
buffer
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014540118A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532718A (ja
JP6356607B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/063242 external-priority patent/WO2013067301A1/en
Publication of JP2014532718A publication Critical patent/JP2014532718A/ja
Publication of JP2014532718A5 publication Critical patent/JP2014532718A5/ja
Application granted granted Critical
Publication of JP6356607B2 publication Critical patent/JP6356607B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014540118A 2011-11-02 2012-11-02 オーバーロード/溶出クロマトグラフィー Active JP6356607B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161554898P 2011-11-02 2011-11-02
US61/554,898 2011-11-02
PCT/US2012/063242 WO2013067301A1 (en) 2011-11-02 2012-11-02 Overload and elute chromatography

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018113263A Division JP2018184405A (ja) 2011-11-02 2018-06-14 オーバーロード/溶出クロマトグラフィー

Publications (3)

Publication Number Publication Date
JP2014532718A JP2014532718A (ja) 2014-12-08
JP2014532718A5 true JP2014532718A5 (enExample) 2015-12-24
JP6356607B2 JP6356607B2 (ja) 2018-07-11

Family

ID=48192803

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014540118A Active JP6356607B2 (ja) 2011-11-02 2012-11-02 オーバーロード/溶出クロマトグラフィー
JP2018113263A Pending JP2018184405A (ja) 2011-11-02 2018-06-14 オーバーロード/溶出クロマトグラフィー
JP2019209674A Active JP6979442B2 (ja) 2011-11-02 2019-11-20 オーバーロード/溶出クロマトグラフィー
JP2021185350A Active JP7203928B2 (ja) 2011-11-02 2021-11-15 オーバーロード/溶出クロマトグラフィー

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018113263A Pending JP2018184405A (ja) 2011-11-02 2018-06-14 オーバーロード/溶出クロマトグラフィー
JP2019209674A Active JP6979442B2 (ja) 2011-11-02 2019-11-20 オーバーロード/溶出クロマトグラフィー
JP2021185350A Active JP7203928B2 (ja) 2011-11-02 2021-11-15 オーバーロード/溶出クロマトグラフィー

Country Status (25)

Country Link
US (3) US20140301977A1 (enExample)
EP (3) EP3527274B1 (enExample)
JP (4) JP6356607B2 (enExample)
KR (1) KR20140091721A (enExample)
CN (2) CN104023804B (enExample)
AU (1) AU2012323995B2 (enExample)
BR (1) BR112014010406A2 (enExample)
CA (1) CA2854330A1 (enExample)
DK (2) DK3257564T4 (enExample)
ES (3) ES3062963T3 (enExample)
FI (1) FI3257564T4 (enExample)
HR (2) HRP20260140T1 (enExample)
HU (2) HUE043755T2 (enExample)
IL (1) IL232146A0 (enExample)
LT (1) LT3257564T (enExample)
MX (1) MX2014005330A (enExample)
PL (3) PL2773438T5 (enExample)
PT (1) PT3257564T (enExample)
RS (1) RS58472B2 (enExample)
RU (1) RU2014121884A (enExample)
SG (1) SG11201402019TA (enExample)
SI (2) SI2773438T2 (enExample)
TR (1) TR201903707T4 (enExample)
WO (1) WO2013067301A1 (enExample)
ZA (1) ZA201402932B (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9029517B2 (en) 2010-07-30 2015-05-12 Emd Millipore Corporation Chromatography media and method
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
EP3527274B1 (en) 2011-11-02 2025-12-24 F. Hoffmann-La Roche AG Overload and elute chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9249182B2 (en) * 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CN104884147A (zh) 2012-10-24 2015-09-02 建新公司 使用mes和mops作为流动相改性剂从多峰树脂洗脱生物分子
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
WO2015088677A1 (en) 2013-12-12 2015-06-18 Emd Millipore Corporation Protein separations using an acrylamide containing filter
CN106068127B (zh) * 2013-12-13 2020-06-19 诺和诺德保健股份有限公司 蛋白质的硫醚缀合方法
KR20150083689A (ko) * 2014-01-10 2015-07-20 삼성전자주식회사 항 c-Met 항체 정제 방법
SI3116891T1 (sl) 2014-03-10 2020-07-31 Richter Gedeon Nyrt. Čiščenje imunoglobulina z uporabo predčistilnih stopenj
US10252258B2 (en) * 2014-03-24 2019-04-09 Nitto Boseki Co., Ltd. Method for separating and concentrating target substance using novel cationic graft polymer
SG11201609908VA (en) * 2014-05-28 2016-12-29 Agency Science Tech & Res Virus reduction method
KR20170026521A (ko) * 2014-06-25 2017-03-08 제이에이치엘 바이오테크 인코포레이티드 단백질의 정제를 위한 방법 및 시약
CN104208719B (zh) * 2014-09-24 2017-05-03 北京天广实生物技术股份有限公司 一种抗体偶联药物的阳离子交换层析纯化方法
US20170298091A1 (en) 2014-12-08 2017-10-19 Emd Millipore Corporation Mixed Bed Ion Exchange Adsorber
SG10202005917SA (en) * 2015-03-06 2020-07-29 Genentech Inc Ultrapurified dsba and dsbc and methods of making and using the same
CN106290591B (zh) * 2015-05-14 2019-07-26 上海医药工业研究院 一种庆大霉素C1a的检测方法
GB2539420B (en) * 2015-06-16 2021-01-13 Cytiva Sweden Ab Determination of chromatography conditions
ES2877532T3 (es) 2015-08-21 2021-11-17 Hoffmann La Roche Procedimiento para la reducción de proteínas de célula huésped en cromatografía de afinidad
WO2017032610A1 (en) * 2015-08-21 2017-03-02 F. Hoffmann-La Roche Ag Affinity chromatography purification with low conductivity wash buffer
JP7286536B2 (ja) * 2016-08-15 2023-06-05 ジェネンテック, インコーポレイテッド 非イオン性サーファクタント及びポリペプチドを含む組成物中の非イオン性サーファクタントを定量するためのクロマトグラフィー法
GB201702856D0 (en) * 2017-02-22 2017-04-05 Ge Healthcare Bio Sciences Ab Method in continuous chromatography
WO2019092084A1 (en) * 2017-11-08 2019-05-16 Blue Sky Vaccines Gmbh So3 chromatography for use in a method for virus purification
CA3104392A1 (en) * 2018-07-04 2020-01-09 Probiogen Ag Method for purifying an enveloped virus
WO2020128797A1 (en) * 2018-12-21 2020-06-25 3M Innovative Properties Company Method for testing a chromatography device used for ion exchange
US20220135619A1 (en) 2019-02-24 2022-05-05 Bristol-Myers Squibb Company Methods of isolating a protein
AR119264A1 (es) 2019-06-05 2021-12-09 Genentech Inc Método para reutilización de cromatografía
CN111351876A (zh) * 2020-04-01 2020-06-30 上海中科新生命生物科技有限公司 一种抗体药中宿主细胞蛋白半绝对定量检测方法
US11379651B1 (en) * 2020-07-06 2022-07-05 Turtl Surf & Immerse Limited Methods and systems for interactive content creation
US12486525B2 (en) 2020-09-22 2025-12-02 Bristol-Myers Squibb Company Methods for increasing productivity of therapeutic proteins
CN116802206A (zh) * 2020-12-28 2023-09-22 等离子体技术有限责任公司 用于生产规模的免疫球蛋白g分离系统和方法
JP7620456B2 (ja) * 2021-03-15 2025-01-23 株式会社カネカ κ鎖を含む抗体の製造方法
WO2023053030A1 (en) * 2021-09-28 2023-04-06 Kashiv Biosciences, Llc An improved process for purification of protein

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
EP0479909B1 (en) 1989-06-29 1996-10-30 Medarex, Inc. Bispecific reagents for aids therapy
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
ATE204902T1 (de) 1990-06-29 2001-09-15 Large Scale Biology Corp Melaninproduktion durch transformierte mikroorganismen
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
ATE255131T1 (de) 1991-06-14 2003-12-15 Genentech Inc Humanisierter heregulin antikörper
MX9204374A (es) 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
DE69233528T2 (de) 1991-11-25 2006-03-16 Enzon, Inc. Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen
WO1993016185A2 (en) 1992-02-06 1993-08-19 Creative Biomolecules, Inc. Biosynthetic binding protein for cancer marker
ATE244763T1 (de) 1992-02-11 2003-07-15 Cell Genesys Inc Erzielen von homozygotem durch zielgerichtete genetische ereignisse
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
EP0656064B1 (en) 1992-08-17 1997-03-05 Genentech, Inc. Bispecific immunoadhesins
DE69303494T2 (de) 1992-11-13 1997-01-16 Idec Pharma Corp Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5712374A (en) 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
PT1538202E (pt) * 1996-09-13 2014-04-22 Shire Human Genetic Therapies Produção de alga-galactosidase a humana
ES2337091T3 (es) * 1996-11-27 2010-04-20 Genentech, Inc. Purificacion por afinidad de polipeptido en una matriz de proteina.
BRPI9910332B8 (pt) * 1998-05-06 2021-05-25 Genentech Inc método para purificação de um polipeptídio a partir de uma composição
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
ES2376454T3 (es) 2000-12-22 2012-03-14 Grad, Carole, Legal Representative Of Howard, Kaplan Librer�?as de expresión en fago de fragmentos vh humanos.
TR200301208T2 (tr) * 2001-02-01 2005-05-23 Biogen, Inc. Nublastin polimer eşlenikleri ve bunları kullanma yöntemleri.
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
US20070261962A1 (en) * 2002-04-02 2007-11-15 Ryszard Gajek Separation Systems with Charge Mosaic Membrane
KR100668573B1 (ko) * 2002-10-18 2007-01-16 아사히 카세이 메디칼 가부시키가이샤 친수성 미다공막
SI1639011T1 (sl) 2003-06-30 2009-04-30 Domantis Ltd Pegilirana protitelesa z enojno domeno (dAb)
WO2006031370A2 (en) 2004-08-19 2006-03-23 Genentech, Inc. Polypeptide variants with altered effector function
ES2579805T3 (es) 2004-09-23 2016-08-16 Genentech, Inc. Anticuerpos y conjugados modificados por ingeniería genética con cisteína
DK1869065T3 (da) 2005-03-11 2020-06-08 Wyeth Llc Fremgangsmåde til kromatografi med svag opdeling
US8153009B2 (en) * 2005-04-22 2012-04-10 Waters Technologies Corporation Apparatus and methods for mass-spectrometric directed purification of biopolymers
BRPI0716139A2 (pt) * 2006-08-28 2013-09-17 Ares Trading Sa processo para purificaÇço de proteÍnas de fusço fc
MY157846A (en) * 2006-08-28 2016-07-29 Ares Trading Sa Process for the purification of fc-containing proteins
MX2009012786A (es) 2007-06-01 2009-12-10 Hoffmann La Roche Purificacion de inmunoglobulina.
DE102009005479A1 (de) * 2009-01-21 2010-07-22 Sartorius Stedim Biotech Gmbh Vorrichtung und Verfahren für die Stofftrennung
JP5614936B2 (ja) * 2009-02-19 2014-10-29 旭化成ケミカルズ株式会社 アニオン交換基が固定された多孔膜を用いた核酸の精製方法
ES2817802T3 (es) * 2009-08-07 2021-04-08 Emd Millipore Corp Métodos para purificar una proteína objetivo de una o más impurezas en una muestra
WO2011035282A1 (en) * 2009-09-21 2011-03-24 Ge Healthcare Bio-Sciences Ab Dual capture separation
CN102094034A (zh) * 2009-12-09 2011-06-15 泰州新生源生物医药有限公司 一种重组人Fc融合长效干扰素的纯化工艺
WO2012030512A1 (en) * 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
AU2011329053A1 (en) 2010-11-15 2013-06-06 Biogen Inc. Enrichment and concentration of select product isoforms by overloaded bind and elute chromatography
EP3527274B1 (en) 2011-11-02 2025-12-24 F. Hoffmann-La Roche AG Overload and elute chromatography

Similar Documents

Publication Publication Date Title
RU2014121884A (ru) Хроматография перегрузки и элюирования
RU2014121886A (ru) Устройство для обработки курительного изделия и картридж для него
US9957318B2 (en) Protein purification methods to reduce acidic species
EP3912987B9 (en) Purification platform for bispecific antibodies
US7691980B2 (en) Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
JP2016530533A5 (enExample)
JP5567691B2 (ja) Fc含有タンパク質を精製するためのクロマトグラフィー法
JP4852602B2 (ja) 抗体の精製法
JP2013530156A5 (enExample)
US20120077961A1 (en) Enhanced purification of antibodies and antibody fragments by apatite chromatography
WO2013176754A9 (en) Novel purification of antibodies using hydrophobic interaction chromatography
CA2903496A1 (en) Methods of increasing protein purity using protein a based chromatography
CN108350027A (zh) 用于改进的蛋白质分离的相反的pH-盐梯度
CN108350026A (zh) 离子交换色谱法中改进的蛋白质分离
EP4026596A1 (en) Removal of leaked affinity purification ligand
CN104136121A (zh) 减少离子交换色谱中的pH漂移
CN112771379A (zh) 用于测定多聚体蛋白质的量和纯度的方法和色谱系统
KR101700580B1 (ko) 양이온 교환 크로마토그래피를 이용한 항체의 아형 분리 방법
CN106414495A (zh) 抗体处理方法
JP2014523405A5 (enExample)
Ishihara et al. Evaluation of new affinity chromatography resins for polyclonal, oligoclonal and monoclonal antibody pharmaceuticals
Liu et al. Comparison of camelid antibody ligand to protein A for monoclonal antibody purification
CN117126227A (zh) 表面活性剂在疏水层析纯化蛋白中提高回收率的应用
KR20240154657A (ko) 임상 인간 igg 제품의 친화도 크로마토그래피 생산
HK1174044B (en) Chromatographic method for purifying fc-containing proteins